Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,289 papers from all fields of science
Search
Sign In
Create Free Account
Delayed Release Tablet Dosage Form
Known as:
Tablet, delayed release
, Delayed Release Tablet Dose Form
, TAB DR
Expand
A tablet that has been coated with a substance that is designed to impede the immediate release of the active and/or inert ingredient(s) after…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC SDTM Pharmaceutical Dosage Form Terminology
Clinical Data Interchange Standards Consortium Terminology
Structured Product Labeling Pharmaceutical Dosage Form Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.
D. Baviskar
,
Amarjitsing Rajput
,
+4 authors
D. Jain
Pakistan Journal of Pharmaceutical Sciences
2014
Corpus ID: 24586352
The main objective behind this study was to formulate delayed release colon targeted tablet of Mebendazole by using different…
Expand
2012
2012
Azulfidine EN-tabs® sulfasalazine delayed release tablets, USP Enteric-coated Tablets DESCRIPTION AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric…
2012
Corpus ID: 19883574
CLINICAL PHARMACOLOGY Pharmacodynamics The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5…
Expand
2012
2012
1.International Journal of Drug Development and Research
Patel Harshna
,
S. SolankiN
2012
Corpus ID: 56773000
The best new therapeutic entity in the world is of little value without an appropriate delivery system. The most important role…
Expand
2007
2007
LIALDATM (mesalamine) Delayed Release Tablets DESCRIPTION Each LIALDA delayed release tablet for oral administration contains 1.2g 5-aminosalicylic acid (5-ASA; mesalamine), an anti-inflammatory…
Lialda 1.2g
2007
Corpus ID: 42455721
The mechanism of action of mesalamine is not fully understood, but appears to be topical. Mucosal production of arachidonic acid…
Expand
2001
2001
Bioavailability and stability of erythromycin delayed release tablets.
S. Ogwal
,
T. U. Xide
African Health Sciences
2001
Corpus ID: 30601162
BACKGROUND Erythromycin is available as the free base, ethylsuccinate, estolate, stearate, gluceptate, and lactobionate…
Expand
1984
1984
Polyacrylic acid ester was used as the substrate, the divisibility, the active substance delayed release tablet
アルン・ラヤラム・グプテ
,
ベルント・ジエレンベルグ
1984
Corpus ID: 146117699
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE